QGenome Downloads & RevenueQGenome · App Store
Not in any tracked top chart right now.
Updated 7 Nov 2026 · rankings refresh through the day
DeveloperUBQO Limited
CategoryMedical
PriceFree
Released
Rating★ 4.0 (8)
Version3.1
Age rating17+
First seen by us
23 Oct 2026
23 Oct 2026Full timeline · 2 events in the last 12 months
- 🆕QGenome first spotted by AppInsiderUnited Kingdom (found via developer)
- 🆕QGenome released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
4.0 ★
8 ratings
Measured
QGenome on the App Store
App details
App ID
999802455
Publisher
UBQO Limited
On the store since
Feb 2016
10 years on the store
Minimum OS
iOS 12.0+
iPhone 5s and later
Devices
iPhone · iPad
Universal purchase
Content rating
17+
1 content note below
Languages
1
EN
Size
137 MB
Also listed in
Reference
Content notesFrequent/Intense Medical/Treatment Information
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
4.0 ★
8 ratings
Measured
Ratings
8
Measured
About QGenome
QGenome has been developed by Guy's and St Thomas' NHS Foundation Trust's Regional Genetics service, a partner in the South East Genomic Medicine Service Alliance, and UBQO to provide streamlined inherited genomic risk assessment, testing and referral guidance in an accessible and user-friendly format.
QGenome enables users to decide which patients may be eligible for genomic investigations and risk assessment, in line with the NHSE Genomic Test Directory and published literature. It provides clinicians with a framework of questions that can be used in their clinical approach when managing patients who are concerned about an inherited susceptibility to disease.
The application allows users to access up to date clinical guidance, at the ‘point of care’, and delivers a time-efficient mechanism to instigate genomic evaluation and onward referrals, where necessary.
The aim of QGenome is to facilitate streamlined quicker access to enhanced surveillance, risk-reduction options, genetic counselling, genomic testing and multidisciplinary care for patients and their families.
QGenome enables users to decide which patients may be eligible for genomic investigations and risk assessment, in line with the NHSE Genomic Test Directory and published literature. It provides clinicians with a framework of questions that can be used in their clinical approach when managing patients who are concerned about an inherited susceptibility to disease.
The application allows users to access up to date clinical guidance, at the ‘point of care’, and delivers a time-efficient mechanism to instigate genomic evaluation and onward referrals, where necessary.
The aim of QGenome is to facilitate streamlined quicker access to enhanced surveillance, risk-reduction options, genetic counselling, genomic testing and multidisciplinary care for patients and their families.
Latest updates
3.1
Final version
